The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 25, 2021
Filed:
May. 12, 2015
Applicant:
The Board of Regents of the University of Texas System, Austin, TX (US);
Inventors:
Chengcheng Zhang, Dallas, TX (US);
Yi Liu, Dallas, TX (US);
Junke Zheng, Shanghai, CN;
Mi Deng, Plano, TX (US);
Chuo Chen, Dallas, TX (US);
Jiawei Liu, Changsha, CN;
Assignee:
The Board of Regents of the University of Texas System, Austin, TX (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/194 (2006.01); A61K 31/197 (2006.01); C12N 5/078 (2010.01); C12N 5/0789 (2010.01); A61K 31/155 (2006.01); A61K 31/20 (2006.01); C07C 279/14 (2006.01); A61K 45/06 (2006.01); A61K 35/65 (2015.01); A61K 38/01 (2006.01);
U.S. Cl.
CPC ...
A61K 31/194 (2013.01); A61K 31/155 (2013.01); A61K 31/197 (2013.01); A61K 31/20 (2013.01); A61K 45/06 (2013.01); C12N 5/0634 (2013.01); C12N 5/0647 (2013.01); A61K 35/65 (2013.01); A61K 38/012 (2013.01); C07C 279/14 (2013.01);
Abstract
The present disclosure relates to methods of using a compound to induce regeneration of hematopoietic stem cells or increase the recovery of red blood cells. In some aspects, the present methods can be used to with or in place of erythropoietin in patients to mitigate the side effects of erythropoietin.